Edition:
India

Insmed Inc (INSM.OQ)

INSM.OQ on NASDAQ Stock Exchange Global Select Market

21.31USD
21 Sep 2018
Change (% chg)

$-0.42 (-1.93%)
Prev Close
$21.73
Open
$21.76
Day's High
$22.47
Day's Low
$21.02
Volume
997,742
Avg. Vol
250,020
52-wk High
$33.94
52-wk Low
$18.67

Chart for

About

Insmed Incorporated is a biopharmaceutical company. The Company operates through development and commercialization of therapies for patients with rare diseases segment. Its lead product candidate is ARIKAYCE, or liposomal amikacin for inhalation (LAI), which is in late-stage development for adult patients with treatment... (more)

Overall

Beta: 1.20
Market Cap(Mil.): $2,392.91
Shares Outstanding(Mil.): 76.50
Dividend: --
Yield (%): --

Financials

BRIEF-Insmed Reports Q1 Loss Per Share $0.89

* INSMED REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

02 May 2018

BRIEF-Insmed Inc Submits NDA To FDA For ALIS

* INSMED SUBMITS NEW DRUG APPLICATION TO FDA FOR ALIS IN NTM LUNG DISEASE CAUSED BY MAC

29 Mar 2018

Competitors

Earnings vs. Estimates